[ad_1]
However, the situation in the media market is constantly changing: if you want to support quality business journalism and want to be part of the Portfolio community, subscribe to Portfolio Signature articles. Know more
According to the US health news portal, the test subject is on the mend and is likely to leave the hospital on Wednesday.
The American newspaper The New York Times previously reported, citing a known source, that the health problem involves inflammation of the spinal cord, which can also be caused by a viral infection.
Stat News reported Wednesday that tests for a coronavirus vaccine at the British and Swedish-owned pharmaceutical company AstraZeneca had been suspended for safety reasons after one of the test subjects was suspected of having a health problem. serious.
The British newspaper Financial Times, citing sources familiar with the case, reported on Wednesday that testing of AstraZeneca’s coronavirus vaccine could continue next week.
The coronavirus vaccine, developed by AstraZeneca and the University of Oxford, is being tested in the United States and the United Kingdom, among others.
On Tuesday, nine vaccine manufacturers from the US and Europe assured everyone that safety standards were being met. AstraZeneca, Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Moderna, Novavax, Sanofi and BioNTech have committed to respecting the integrity of the scientific process in vaccine development, following growing concerns, that compliance with safety standards it can be undermined by political pressure to accelerate vaccine development. Above all, US President Donald Trump is voicing that by the end of the year, but there may be a vaccine until the presidential election on November 3.
Cover image: Getty Images
[ad_2]
